Suppr超能文献

克罗地亚医学生物化学和实验室医学学会:凝血筛选检测(凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原和 D-二聚体)的血液采集、处理、性能和结果报告的国家建议。

Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer.

机构信息

Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.

Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.

出版信息

Biochem Med (Zagreb). 2019 Jun 15;29(2):020503. doi: 10.11613/BM.2019.020503.

Abstract

A modern diagnostic laboratory offers wide spectrum of coagulation assays utilized in the diagnosis and management of patients with haemostatic disorders, preoperative screening and anticoagulation therapy monitoring. The recent survey conducted among Croatian medical biochemistry and transfusion laboratories showed the existence of different practice policies in particular phases of laboratory process during coagulation testing and highlighted areas that need improvement. Lack of assay standardization together with non-harmonized test results between different measurement methods, can potentially lead to incorrect decisions in patient's treatment. Consequently, patient safety could be compromised. Therefore, recommended procedures related to preanalytical, analytical and postanalytical phases of prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer testing are provided in this review, aiming to help laboratories to generate accurate and reliable test results.

摘要

现代化的诊断实验室提供广泛的凝血检测,用于诊断和管理止血障碍患者、术前筛查和抗凝治疗监测。最近在克罗地亚医学生物化学和输血实验室进行的一项调查显示,在凝血检测的实验室过程的特定阶段存在不同的实践政策,并强调了需要改进的领域。缺乏检测标准化以及不同测量方法之间的测试结果不统一,可能导致患者治疗决策的错误。因此,患者安全可能受到影响。因此,本综述提供了与凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原和 D-二聚体检测的分析前、分析中和分析后阶段相关的推荐程序,旨在帮助实验室生成准确可靠的检测结果。

相似文献

3
Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatran.
Pathology. 2021 Aug;53(5):623-627. doi: 10.1016/j.pathol.2020.10.017. Epub 2021 Jan 30.
4
Effect of specimen collection on routine coagulation assays and D-dimer measurement.
Clin Chem. 2004 Nov;50(11):2150-2. doi: 10.1373/clinchem.2004.036244.
5
Routine Coagulation.
Clin Lab Med. 2024 Sep;44(3):527-539. doi: 10.1016/j.cll.2024.04.012. Epub 2024 Jun 4.
6
[Diagnostic of blood coagulation].
Hamostaseologie. 2008 Dec;28(5):320-34.
10
Influence of temperature and time before centrifugation of specimens for routine coagulation testing.
Int J Lab Hematol. 2009 Aug;31(4):462-7. doi: 10.1111/j.1751-553X.2008.01058.x. Epub 2008 Mar 21.

引用本文的文献

1
Coagulation markers as independent predictors of colorectal cancer aggressiveness.
BMC Gastroenterol. 2025 Sep 2;25(1):634. doi: 10.1186/s12876-025-04249-4.
2
Inflammation, immunity and biomarkers in procoagulant responses of critically ill patients.
Am J Transl Res. 2024 Oct 15;16(10):5797-5812. doi: 10.62347/EDAR9565. eCollection 2024.
3
A Real-World Study on the Short-Term Efficacy of Amlodipine in Treating Hypertension Among Inpatients.
Pragmat Obs Res. 2024 Aug 6;15:121-137. doi: 10.2147/POR.S464439. eCollection 2024.
4
Nomogram for Risk of Secondary Venous Thromboembolism in Stroke Patients: A Study Based on the MIMIC-IV Database.
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241254104. doi: 10.1177/10760296241254104.
5
Saudi expert consensus on acquired hemophilia A diagnosis and management.
J Taibah Univ Med Sci. 2024 Apr 27;19(3):566-574. doi: 10.1016/j.jtumed.2024.04.006. eCollection 2024 Jun.
7
Advances in haemostatic sponges: Characteristics and the underlying mechanisms for rapid haemostasis.
Bioact Mater. 2023 Apr 13;27:231-256. doi: 10.1016/j.bioactmat.2023.04.008. eCollection 2023 Sep.
10
Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?
Biochem Med (Zagreb). 2021 Jun 15;31(2):020708. doi: 10.11613/BM.2021.020708.

本文引用的文献

1
Preanalytical Issues in Hemostasis and Thrombosis Testing.
Methods Mol Biol. 2017;1646:29-42. doi: 10.1007/978-1-4939-7196-1_2.
2
Establishing reference intervals in the coagulation laboratory.
Int J Lab Hematol. 2017 May;39 Suppl 1:121-127. doi: 10.1111/ijlh.12661.
5
Critical laboratory values in hemostasis: toward consensus.
Ann Med. 2017 Sep;49(6):455-461. doi: 10.1080/07853890.2016.1278303. Epub 2017 Feb 10.
6
Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories.
Thromb J. 2016 Dec 12;14:49. doi: 10.1186/s12959-016-0123-z. eCollection 2016.
7
Explaining and reducing the variation in inter-laboratory reported values for International Normalised Ratio.
Thromb Res. 2017 Feb;150:22-29. doi: 10.1016/j.thromres.2016.12.007. Epub 2016 Dec 14.
8
Mixing of thawed coagulation samples prior to testing: Is any technique better than another?
Clin Biochem. 2016 Dec;49(18):1399-1401. doi: 10.1016/j.clinbiochem.2016.10.009. Epub 2016 Oct 18.
9
Assuring the quality of interpretative comments in clinical chemistry.
Clin Chem Lab Med. 2016 Dec 1;54(12):1901-1911. doi: 10.1515/cclm-2016-0709.
10
How to report results of prothrombin and activated partial thromboplastin times.
Clin Chem Lab Med. 2016 Feb;54(2):215-22. doi: 10.1515/cclm-2015-0657.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验